Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators-Reference-Cited by-同舟云学术

Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators

Published:2024-04-27 Issue:8 Volume:15 Page:1151-1160
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J of Diabetes Invest

Author:

Shen Feng‐Chih¹²^ORCID,Chu Chih‐Hsun³,Chen Jung‐Fu¹²,Kuo Chin‐Sung⁴⁵,Hsu Chih‐Yao⁶^ORCID,Lin Ching‐Han⁷,Sheen Yi‐Jing⁸⁹¹⁰,Su Sheng‐Chiang¹¹,Tien Kai‐Jen¹²,Lu Chieh‐Hua¹¹^ORCID,Lee Chun‐Chuan¹³¹⁴,Yang Yi‐Sun¹⁵¹⁶,Tu Shih‐Te¹⁷^ORCID,Chen Po‐Tsang¹⁸,Chen Ching‐Chu¹⁹²⁰^ORCID,Chien Ming‐Nan¹³¹⁴,Li Hung‐Yuan²¹^ORCID,Sheu Wayne Huey‐Herng⁹²²^ORCID,Huang Chien‐Ning¹⁵¹⁶,Wang Chih‐Yuan²¹²³^ORCID,Ou Horng‐Yih⁷^ORCID

Affiliation:

1. Division of Endocrinology and Metabolism, Department of Internal Medicine Kaohsiung Chang Gung Memorial Hospital Kaohsiung Taiwan

2. School of Medicine, College of Medicine Chang Gung University Taoyuan Taiwan

3. Division of Endocrinology and Metabolism, Department of Internal Medicine Kaohsiung Veterans General Hospital Kaohsiung Taiwan

4. Institute of Clinical Medicine National Yang Ming Chiao Tung University Taipei Taiwan

5. Division of Endocrinology and Metabolism, Department of Medicine Taipei Veterans General Hospital Taipei Taiwan

6. Department of Internal Medicine Taipei City Hospital, Ren‐Ai Branch Taipei Taiwan

7. Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine National Cheng Kung University Tainan Taiwan

8. Division of Endocrinology and Metabolism, Department of Internal Medicine Taichung Veterans General Hospital Taichung City Taiwan

9. School of Medicine, College of Medicine National Yang Ming Chiao Tung University Taipei Taiwan

10. Department of Post‐Baccalaureate Medicine, College of Medicine National Chung Hsing University Taichung Taiwan

11. Division of Endocrinology and Metabolism, Department of Internal Medicine Tri‐Service General Hospital, National Defense Medical Center Taipei Taiwan

12. Renxin Clinics Tainan Taiwan

13. Division of Endocrinology and Metabolism, Department of Internal Medicine MacKay Memorial Hospital Taipei Taiwan

14. Department of Medicine MacKay Medical College New Taipei City Taiwan

15. Division of Endocrinology and Metabolism, Department of Internal Medicine Chung Shan Medical University Hospital Taichung Taiwan

16. School of Medicine Chung Shan Medical University Taichung Taiwan

17. Division of Endocrinology and Metabolism, Department of Medicine Changhua Christian Hospital Changhua Taiwan

18. Yong De‐Kang Internal Medicine Clinic Tainan Taiwan

19. Division of Endocrinology and Metabolism, Department of Internal Medicine China Medical University Hospital Taichung Taiwan

20. School of Chinese Medicine China Medical University Taichung Taiwan

21. Division of Endocrinology and Metabolism, Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan

22. Institute of Molecular and Genetic Medicine National Health Research Institutes Miaoli Taiwan

23. Department of Internal Medicine National Taiwan University College of Medicine Taipei Taiwan

Abstract

AbstractWe present an in‐depth analysis of dyslipidemia management strategies for patients with diabetes mellitus in Taiwan. It critically examines the disparity between established guideline recommendations and actual clinical practices, particularly in the context of evolving policies affecting statin prescriptions. The focus is on synthesizing the most recent findings concerning lipid management in patients with diabetes mellitus, with a special emphasis on establishing consensus regarding low‐density lipoprotein cholesterol treatment targets. The article culminates in providing comprehensive, evidence‐based recommendations tailored to the unique needs of those living with diabetes mellitus in Taiwan. It underscores the criticality of personalized care approaches, which incorporate multifaceted factors, and the integration of novel therapeutic options to enhance cardiovascular health outcomes.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.14222

Reference91 articles.

1. Utilization of statins and aspirin among patients with diabetes and hyperlipidemia: Taiwan, 1998–2006☆

2. Impact of changing reimbursement criteria on statin treatment patterns among patients with atherosclerotic cardiovascular disease or cardiovascular risk factors

3. 10-year trends in statin utilization in Taiwan: a retrospective study using Taiwan’s National Health Insurance Research Database

4. National survey of ABC (A1C, blood pressure, cholesterol) of Diabetes Health Promotion Institutes in Taiwan: 2002–2018

5. Trends of ABC control 2006–2011: A National Survey of Diabetes Health Promotion Institutes in Taiwan